Jue (Michelle) Wang, PhD

Jue (Michelle) Wang, PhD, is assistant director, purification process development, at Medarex Inc.

Precipitation prior to capture chromatography offers a simple, robust, and economical method to remove CHO host cell proteins and DNA.

In three non-affinity purification processes based on cation exchange capture with high binding capacity, applying a host cell protein exclusion strategy enabled robust scale up and better economics.

An alternative approach to traditional Protein A schemes is comparable in overall efficiency, product recovery, and quality.

Affinity purification schemes for antibody production have certain limitations keeping up with cell culture expression levels as they reach and exceed 10 g/L. New downstream purification processes are based on low cost, long lasting, and high binding (40–100 mg/mL) cation exchange resins.